You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 11, 2024

SILDENAFIL CITRATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sildenafil Citrate patents expire, and what generic alternatives are available?

Sildenafil Citrate is a drug marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Amneal Pharms, Aurobindo Pharma Ltd, Granules, Hetero Labs Ltd V, Invagen Pharms, Lupin Ltd, MSN, Novitium Pharma, Somerset Theraps Llc, Taro, Teva Pharms Usa, Tris Pharma Inc, Zydus Lifesciences, Eugia Pharma, Actavis Grp Ptc, Amneal Pharms Ny, Apotex Corp, Appco, Cadila Pharms Ltd, Chartwell Rx, Macleods Pharms Ltd, Mylan, Mylan Pharms Inc, Perrigo R And D, Reyoung, Rubicon, Sunshine, Teva, Teva Pharms, Torrent, Torrent Pharms Ltd, Umedica, and Watson Labs Inc. and is included in forty-seven NDAs.

The generic ingredient in SILDENAFIL CITRATE is sildenafil citrate. There are twenty drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sildenafil Citrate

A generic version of SILDENAFIL CITRATE was approved as sildenafil citrate by CHARTWELL RX on November 6th, 2012.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SILDENAFIL CITRATE?
  • What are the global sales for SILDENAFIL CITRATE?
  • What is Average Wholesale Price for SILDENAFIL CITRATE?
Drug patent expirations by year for SILDENAFIL CITRATE
Drug Prices for SILDENAFIL CITRATE

See drug prices for SILDENAFIL CITRATE

Drug Sales Revenue Trends for SILDENAFIL CITRATE

See drug sales revenues for SILDENAFIL CITRATE

Recent Clinical Trials for SILDENAFIL CITRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Batterjee Medical CollegePhase 4
University of PennsylvaniaPhase 2
Ladoke Akintola University of Technology Teaching Hospital, OgbomosoPhase 4

See all SILDENAFIL CITRATE clinical trials

Pharmacology for SILDENAFIL CITRATE
Medical Subject Heading (MeSH) Categories for SILDENAFIL CITRATE
Anatomical Therapeutic Chemical (ATC) Classes for SILDENAFIL CITRATE
Paragraph IV (Patent) Challenges for SILDENAFIL CITRATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
VIAGRA Tablets sildenafil citrate 25 mg and 50 mg 020895 1 2004-11-19
VIAGRA Tablets sildenafil citrate 100 mg 020895 1 2004-10-25

US Patents and Regulatory Information for SILDENAFIL CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Torrent SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 091448-001 Jun 11, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hetero Labs Ltd V SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 203623-001 Nov 26, 2014 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 203962-002 Jun 11, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 201171-001 Mar 25, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Reyoung SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 208494-003 Jun 12, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Macleods Pharms Ltd SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 203814-001 Dec 17, 2013 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 201171-002 Mar 25, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.